Related Experiment Video
Updated: Aug 1, 2025

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
The Novel Role of Noncoding RNAs in Modulating Platelet Function: Implications in Activation and Aggregation
Giovanni Cimmino1,2, Stefano Conte3, Domenico Palumbo1
1Department of Translational Medical Sciences, Section of Cardiology, University of Campania Luigi Vanvitelli, L. Bianchi Street, 80131 Naples, Italy.
Platelets play a key role in acute coronary syndromes (ACSs). This review explores how noncoding RNAs influence platelet activation and aggregation, offering new therapeutic targets for thrombotic disorders.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Hematology
Background:
- Platelet activation and thrombosis are central to acute coronary syndromes (ACSs).
- Despite advances in antithrombotic therapies, cardiovascular events persist in ACS patients.
- Platelet de novo protein synthesis via mRNA translation is crucial for activation.
Purpose of the Study:
- To review the novel role of noncoding RNAs in modulating platelet function.
- To explore the implications of noncoding RNAs in platelet activation and aggregation.
- To identify new therapeutic perspectives for thrombotic disorders like ACSs.
Main Methods:
- Literature review of platelet pathophysiology and noncoding RNA functions.
- Analysis of current understanding of platelet activation mechanisms.
- Discussion of implications for thrombotic disorders.
Main Results:
- Platelets contain mRNAs enabling rapid protein synthesis upon activation.
- Noncoding RNAs emerge as key modulators of platelet activation and aggregation.
- Understanding these mechanisms offers new therapeutic avenues.
Conclusions:
- Noncoding RNAs represent a significant area for understanding platelet function in thrombotic diseases.
- Targeting noncoding RNA pathways may lead to improved treatments for ACSs, stroke, and peripheral artery diseases.
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
lncRNA - Long Non-coding RNAs
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Types of RNA
RNA Performs Diverse...

